Olivia L. Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Olivia L. Lee has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Blaze Ann Carbonell
Department of Ophthalmology, University of California, Irvine, CA; and
2 shared publications - Maria Del Valle Estopinal
Department of Ophthalmology, Gavin Herbert Eye Institute, UC Irvine, Irvine, CA; and
2 shared publications Austin R. Fox
1 shared publication- Austin R. Fox
Department of Ophthalmology, Gavin Herbert Eye Institute, UC Irvine, Irvine, CA; and
1 shared publication - Christopher D. Yang
University of California, Irvine School of Medicine, Irvine, California, United States
1 shared publication Cinthia Kim
1 shared publication
Latest Publications
- Open Access
- 4 August 2026
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 292, 263-274
In Vivo Microscopic Assessment of Ocular Surface Changes Induced By Antiglaucoma Medications
- 4 August 2026
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 292, 263-274
Open AccessIn Vivo Microscopic Assessment of Ocular Surface Changes Induced By Antiglaucoma Medications
- Open Access
- 24 July 2026
- Published by Wolters Kluwer Health in Eye Banking and Corneal Transplantation
- Vol. 5 (3)
A Case of Donor-Transmitted Candida Keratitis Despite Antifungal Fortified Storage Media
Purpose: To present a case of fungal keratitis and subsequent endophthalmitis after penetrating keratoplasty despite storage of donor tissue in media fortified with amphotericin B. Methods: Case report of donor-transmitted fungal keratitis progressing to fungal endophthalmitis despite storage of donor tissue in media fortified with amphotericin B. Results: A 51-year-old woman with recurrent granular corneal dystrophy underwent penetrating keratoplasty in her right eye with donor rim cultures later growing Candida albicans . Within 2 weeks, the eye developed findings concerning for fungal infection that persisted despite empiric antifungal therapy. Repeat penetrating keratoplasty was performed with a culture-negative graft, but fungal keratitis recurred and progressed to fungal endophthalmitis. The patient later developed persistent vision loss from infection-related complications. Conclusions: We present a case of donor-transmitted fungal keratitis progressing to fungal endophthalmitis despite storage of donor tissue in amphotericin B.
- 24 July 2026
- Published by Wolters Kluwer Health in Eye Banking and Corneal Transplantation
- Vol. 5 (3)
Open AccessA Case of Donor-Transmitted Candida Keratitis Despite Antifungal Fortified Storage Media
Purpose: To present a case of fungal keratitis and subsequent endophthalmitis after penetrating keratoplasty despite storage of donor tissue in media fortified with amphotericin B. Methods: Case report of donor-transmitted fungal keratitis progressing to fungal endophthalmitis despite storage of donor tissue in media fortified with amphotericin B. Results: A 51-year-old woman with recurrent granular corneal dystrophy underwent penetrating keratoplasty in her right eye with donor rim cultures later growing Candida albicans . Within 2 weeks, the eye developed findings concerning for fungal infection that persisted despite empiric antifungal therapy. Repeat penetrating keratoplasty was performed with a culture-negative graft, but fungal keratitis recurred and progressed to fungal endophthalmitis. The patient later developed persistent vision loss from infection-related complications. Conclusions: We present a case of donor-transmitted fungal keratitis progressing to fungal endophthalmitis despite storage of donor tissue in amphotericin B.
- 19 May 2026
- Published by Wolters Kluwer Health in Cornea
Acute Calcific Band Keratopathy After Cenegermin Treatment for Neurotrophic Keratitis
Purpose: To describe the risk factors, clinical course, and characteristics of 5 cases of acute calcific band keratopathy (BK) after the use of recombinant human nerve growth factor for neurotrophic keratitis. Methods: A single-center retrospective chart review of 43 eyes of 43 patients previously diagnosed with neurotrophic keratitis from April 2021 to October 2023 was conducted. All patients had previously completed at least one 8-week course of topical cenegermin 0.002%. Five of the 43 cenegermin-treated eyes that developed BK are included in this series. Results: The incidence of BK was 11.6%. The median time from treatment initiation to BK was 8 weeks. A corneal biopsy confirmed the presence of calcification in 2 cases. All 5 patients had persistent calcium deposits after discontinuing treatment. Prolonged epithelial defect healing time while on treatment was observed in patients who developed BK. Conclusions: BK was observed after cenegermin use. Herein, we report a series of 5 cases, which occurred at the same institution. Ethylenediaminetetraacetic acid chelation therapy had variable results, with 4 out of 5 patients requiring repeated surgical intervention because of multiple recurrences of BK.
- 19 May 2026
- Published by Wolters Kluwer Health in Cornea
Acute Calcific Band Keratopathy After Cenegermin Treatment for Neurotrophic Keratitis
Purpose: To describe the risk factors, clinical course, and characteristics of 5 cases of acute calcific band keratopathy (BK) after the use of recombinant human nerve growth factor for neurotrophic keratitis. Methods: A single-center retrospective chart review of 43 eyes of 43 patients previously diagnosed with neurotrophic keratitis from April 2021 to October 2023 was conducted. All patients had previously completed at least one 8-week course of topical cenegermin 0.002%. Five of the 43 cenegermin-treated eyes that developed BK are included in this series. Results: The incidence of BK was 11.6%. The median time from treatment initiation to BK was 8 weeks. A corneal biopsy confirmed the presence of calcification in 2 cases. All 5 patients had persistent calcium deposits after discontinuing treatment. Prolonged epithelial defect healing time while on treatment was observed in patients who developed BK. Conclusions: BK was observed after cenegermin use. Herein, we report a series of 5 cases, which occurred at the same institution. Ethylenediaminetetraacetic acid chelation therapy had variable results, with 4 out of 5 patients requiring repeated surgical intervention because of multiple recurrences of BK.